Related Experiment Videos
Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma
Cancer Treatment Reports
|June 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interpreting the Significance of Changes in Health-Related Quality-of-Life Scores.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2004
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Trends in the sex ratio of cannabis use, harms and perceptions among youth in Ontario, Canada, 1999 to 2023.
Addiction (Abingdon, England)·2026
Effectiveness of colchicine preparation switching in pediatric colchicine-resistant familial Mediterranean fever: a real-world study.
European journal of pediatrics·2026
AOH1996, an Inhibitor of PCNA, Sensitises Breast Cancer Cells to Cytotoxic Chemotherapy.
Breast cancer (Dove Medical Press)·2026